April 30 (Reuters) - Swiss dental implant maker Straumann STMN.S reported organic sales growth of 11% in the first quarter on Wednesday, above expectations, citing strong growth in the Asia Pacific, with a solid patient flow in China.
Its sales grew to 681 million Swiss francs ($826.86 million)in the quarter, beating analysts' expectations of 676 million francs in a Vara consensus.
($1 = 0.8236 Swiss francs)
(Reporting by Bartosz Dabrowski in Gdansk; Editing by Kim Coghill)
((@bartosz.dabrowski@thomsonreuters.com;))